
ELAB vs JUNS
$ELAB vs $JUNS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ELAB vs JUNS: the quick read
- ·ELAB is the larger company by market cap ($2M vs $2M).
- ·JUNS has the smaller float (766K vs 810K), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 12 and 12 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 6% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ELAB and JUNS on TheDesperateTrader.
- Is ELAB or JUNS the better stock?
- "Better" depends on your goal, and these two are not alike. ELAB is the larger company by market cap ($2M vs $2M). JUNS has the smaller float (766K vs 810K), which tends to mean sharper, more volatile moves. These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ELAB and JUNS?
- The differences that matter: they are not in the same business - ELAB is pharmaceutical preparations and JUNS is pharmaceutical preparations; they are similar in size ($2M vs $2M); they trade at very different share prices ($2.95 vs $2.80); ELAB sits at 1% of its 52-week range against 25% for JUNS. Everything above is measured from the latest completed session and SEC filings.
- Which of ELAB and JUNS is more active right now?
- Right now ELAB is at about 0.1x its normal volume and JUNS is at about 0.2x, so JUNS is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ELAB or JUNS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.